Yang Y - Search Results

1

PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids.

Wu Y, Yang Y, Wang W, Sun D, Liang J, Zhu M, Li H, Chen L. Wu Y, et al. Among authors: yang y. Acta Pharm Sin B. 2022 Nov;12(11):4262-4265. doi: 10.1016/j.apsb.2022.07.007. Epub 2022 Jul 16. Acta Pharm Sin B. 2022. PMID: 36386476 Free PMC article. No abstract available.

2

Synthesis of New Lathyrane Diterpenoid Derivatives from Euphorbia lathyris and Evaluation of Their Anti-Inflammatory Activities.

Wang W, Wu Y, Li C, Yang Y, Li X, Li H, Chen L. Wang W, et al. Among authors: yang y. Chem Biodivers. 2020 Feb;17(2):e1900531. doi: 10.1002/cbdv.201900531. Epub 2020 Jan 16. Chem Biodivers. 2020. PMID: 31825561

3

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H. Wu C, et al. Among authors: yang y. Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27. Acta Pharm Sin B. 2020. PMID: 32292689 Free PMC article.

4

Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor.

Sun W, Wu Y, Zheng M, Yang Y, Liu Y, Wu C, Zhou Y, Zhang Y, Chen L, Li H. Sun W, et al. Among authors: yang y. J Med Chem. 2020 Aug 13;63(15):8146-8156. doi: 10.1021/acs.jmedchem.0c00377. Epub 2020 Jul 30. J Med Chem. 2020. PMID: 32667202

5

PROTACs: New method to degrade transcription regulating proteins.

Hu B, Zhou Y, Sun D, Yang Y, Liu Y, Li X, Li H, Chen L. Hu B, et al. Among authors: yang y. Eur J Med Chem. 2020 Dec 1;207:112698. doi: 10.1016/j.ejmech.2020.112698. Epub 2020 Aug 15. Eur J Med Chem. 2020. PMID: 32858471 Review.

6

Furin: A Potential Therapeutic Target for COVID-19.

Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M, Liu Y, Zhang Q, Zhang P, Wang Y, Wang Q, Xu Y, Zhou Y, Zhang Y, Chen L, Li H. Wu C, et al. Among authors: yang k, yang y. iScience. 2020 Oct 23;23(10):101642. doi: 10.1016/j.isci.2020.101642. Epub 2020 Oct 5. iScience. 2020. PMID: 33043282 Free PMC article.

7

Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.

Zheng M, Wu C, Yang K, Yang Y, Liu Y, Gao S, Wang Q, Li C, Chen L, Li H. Zheng M, et al. Among authors: yang k, yang y. Pharmacol Res. 2021 Feb;164:105367. doi: 10.1016/j.phrs.2020.105367. Epub 2020 Dec 8. Pharmacol Res. 2021. PMID: 33307221

8

Targeting SHP2 as a therapeutic strategy for inflammatory diseases.

Liu Y, Yang X, Wang Y, Yang Y, Sun D, Li H, Chen L. Liu Y, et al. Among authors: yang x, yang y. Eur J Med Chem. 2021 Mar 15;214:113264. doi: 10.1016/j.ejmech.2021.113264. Epub 2021 Feb 6. Eur J Med Chem. 2021. PMID: 33582386 Review.

9

3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Li M, Wu C, Yang Y, Zheng M, Yu S, Wang J, Chen L, Li H. Li M, et al. Among authors: yang y. Cell Oncol (Dordr). 2021 Jun;44(3):541-556. doi: 10.1007/s13402-021-00599-9. Epub 2021 Mar 18. Cell Oncol (Dordr). 2021. PMID: 33735398 Review.

10

Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1.

Yang Y, Xiang K, Sun D, Zheng M, Song Z, Li M, Wang X, Li H, Chen L. Yang Y, et al. Bioorg Med Chem. 2021 Apr 15;36:116095. doi: 10.1016/j.bmc.2021.116095. Epub 2021 Feb 26. Bioorg Med Chem. 2021. PMID: 33735687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101,018 results

Search Page